PRRT2 and cancer: In the TME, neurogenic stimuli stimulate receptors on cancer cells, triggering signaling cascades including PI3K/AKT, Ras/ERK, and PLCγ/PKC, which enhance cancer cell survival and proliferation in pancreatic cancer (94).